InvestSMART

Emerald Resources NL (ASX: EMR) - Announcements

Current share price for EMR : $6.240 0.06 (0.95%)+

ASX company news and announcements for Emerald Resources NL (EMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emerald Resources NL (EMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emerald Resources NL (EMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emerald Resources NL (EMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4,140 Exploration and Resource Drilling Update 28 Oct 2026 9:16AM $6.050 $6.240 risen by 3.14%
$4,140 Change in substantial holding - Amendment 26 Oct 2026 8:18AM $5.780 $6.240 risen by 7.96%
$4,140 Change in substantial holding 23 Oct 2026 6:41PM $5.780 $6.240 risen by 7.96%
$4,140 Annual Report to shareholders 19 Oct 2026 7:14PM $6.460 $6.240 fallen by 3.41%
$4,140 Notice of Annual General Meeting/Proxy Form 19 Oct 2026 7:04PM $6.460 $6.240 fallen by 3.41%
$4,140 Letter to Shareholders - AGM Materials 19 Oct 2026 7:03PM $6.460 $6.240 fallen by 3.41%
$4,140 Notification regarding unquoted securities - EMR 9 Oct 2026 7:51PM $6.640 $6.240 fallen by 6.02%
$4,140 Notification of cessation of securities - EMR 9 Oct 2026 7:45PM $6.640 $6.240 fallen by 6.02%
$4,140 Application for quotation of securities - EMR 9 Oct 2026 7:43PM $6.640 $6.240 fallen by 6.02%
$4,140 Options - Exercise, Cancellation and Issue 9 Oct 2026 7:42PM $6.640 $6.240 fallen by 6.02%
$4,140 September 2026 Quarterly Production Update 7 Oct 2026 9:14AM $6.870 $6.240 fallen by 9.17%
$4,140 Date of Annual General Meeting 30 Sep 2026 5:44PM $6.970 $6.240 fallen by 10.47%
$4,140 Application for quotation of securities - EMR 29 Sep 2026 6:35PM $6.920 $6.240 fallen by 9.83%
$4,140 Option Exercise 29 Sep 2026 6:34PM $6.920 $6.240 fallen by 9.83%
$4,140 Becoming a substantial holder 24 Sep 2026 5:11PM $6.970 $6.240 fallen by 10.47%
$4,140 Application for quotation of securities - EMR 23 Sep 2026 5:41PM $7.120 $6.240 fallen by 12.36%
$4,140 Option Exercise 23 Sep 2026 5:41PM $7.120 $6.240 fallen by 12.36%
$4,140 EMR Backed Manda Completes Acquisition and Appoints CEO 22 Sep 2026 9:33AM $7.020 $6.240 fallen by 11.11%
$4,140 Application for quotation of securities - EMR 17 Sep 2026 7:03PM $6.810 $6.240 fallen by 8.37%
$4,140 Option Exercise 17 Sep 2026 7:00PM $6.810 $6.240 fallen by 8.37%
$4,140 Sprott and Macquarie to Back Emerald on Future Acquisitions 16 Sep 2026 8:48AM $6.760 $6.240 fallen by 7.69%
$4,140 Application for quotation of securities - EMR 31 Aug 2026 6:53PM $6.970 $6.240 fallen by 10.47%
$4,140 Option Exercise 31 Aug 2026 6:52PM $6.970 $6.240 fallen by 10.47%
$4,140 Appendix 4G 27 Aug 2026 8:58AM $7.220 $6.240 fallen by 13.57%
$4,140 Annual Report and Appendix 4E 27 Aug 2026 8:58AM $7.220 $6.240 fallen by 13.57%

1 - 25 of 1037 results

Page 1 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.